Senate Finance Medicaid Telehealth Language Is In Draft Bipartisan Gun Deal

Lawmakers advocate use of telehealth in Medicaid and CHIP in order to expand access to mental health services as part of a bipartisan Senate gun control deal unveiled late Tuesday (June 21). The Medicaid and Telehealth section of the draft Safer Communities Act is identical to the language in Section 11 of the Telemental Health Access to Care Act released last month by the Senate Finance Committee. No later than 18 months after the Communities Act is enacted, HHS would...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 06/24/2022
FDA Volume: 
Vol. 28, No. 25
CMS Issue: 
Inside CMS - 06/23/2022
CMS Volume: 
Vol. 25, No. 25
Author: 

CMS Proposes 3.1% ESRD Pay Bump For 2023

CMS on Tuesday (June 21) proposed a fiscal 2023 pay rule for renal dialysis services that the agency expects will lead to an overall 3.1% pay bump from last year, as well as a $6.19 increase to the current base rate. The proposed 2023 end stage renal disease pay rule would also implement a permanent cap on year-to-year wage index decreases. Under the proposed rule for 2023, Medicare expects to pay about $8.2 billion to around 7,800 facilities for their...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 06/23/2022
CMS Volume: 
Vol. 25, No. 25
Author: 

Home Health Agencies Blast Proposed 2023 Cuts, May Go To Hill

Home health providers are set to ask Congress for relief from CMS’ proposed pay cuts for home health agencies for 2023 -- almost 8% of which are based on what the agency sees as changes in behavior tied to the 2020 pay system for the sector -- as they say the cuts undermine patient care. CMS is also looking to find ways to recoup what it says are $2 billion in excess payments through the new payment system for 2020...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 06/23/2022
CMS Volume: 
Vol. 25, No. 25
Author: 






Researchers Say Mark Cuban Drug Venture Could’ve Saved Part D $3.6B

A new report published by the Annals of Internal Medicine found that Medicare Part D could have saved $3.6 billion in 2020 by buying from the Mark Cuban Cost Plus Drug Company, which in January began selling generic drugs at lower prices than what is paid for by most insurers and federal health programs. Billionaire Mark Cuban’s drug venture launched an online pharmacy that currently sells more than 100 generic drugs at the cost of ingredients and manufacturing, including a...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 06/27/2022
IDP Volume: 
Vol. 5, No. 26
Author: 

Industry, Civil Society Groups Frustrated Over TRIPS Compromise

Groups with a variety of views on tweaking aspects of the Trade-Related Aspects of Intellectual Property Rights Agreement for COVID-19 vaccines can agree on one thing: They’re unhappy with the compromise outcome produced by the World Trade Organization at its 12th ministerial last week. The American Enterprise Institute on Tuesday hosted a panel discussion titled “The Debate over Intellectual Property Protections for COVID-19 Vaccines after one year,” which featured discontented responses from both sides of the TRIPS question. “I think...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 06/24/2022
FDA Volume: 
Vol. 28, No. 25
Author: 

Industry, Civil Society Groups Frustrated Over TRIPS Compromise

Groups with a variety of views on tweaking aspects of the Trade-Related Aspects of Intellectual Property Rights Agreement for COVID-19 vaccines can agree on one thing: They’re unhappy with the compromise outcome produced by the World Trade Organization at its 12th ministerial last week. The American Enterprise Institute on Tuesday hosted a panel discussion titled “The Debate over Intellectual Property Protections for COVID-19 Vaccines after one year,” which featured discontented responses from both sides of the TRIPS question. “I think...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 06/27/2022
IDP Volume: 
Vol. 5, No. 26
Author: 


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.